Clinical Trials List
2023-06-01 - 2028-03-31
Phase III
Not yet recruiting4
Recruiting1
ICD-10D47.4
Osteomyelofibrosis
ICD-10D68.51
Activated protein C resistance
ICD-10D68.52
Prothrombin gene mutation
ICD-10D68.59
Other primary thrombophilia
ICD-10D68.61
Antiphospholipid syndrome
ICD-10D68.62
Lupus anticoagulant syndrome
ICD-10D68.69
Other thrombophilia
ICD-10D75.81
Myelofibrosis
ICD-10D75.89
Other specified diseases of blood and blood-forming organs
ICD-10D77
Other disorders of blood and blood-forming organs in diseases classified elsewhere
ICD-10D89.2
Hypergammaglobulinemia, unspecified
ICD-10E88.09
Other disorders of plasma-protein metabolism, not elsewhere classified
ICD-9289.8
Other specified diseases of blood and blood-forming organs
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 李思慧 無
- YAO CHI-YUAN 無
- CHENG-HONG TSAI 無
- Wen-Chien Chou 無
- 田豐銘 無
- MING YAO 無
- 劉高郎 無
- SHAN-CHI YU 無
- - - 無
- Chien-Chin Lin 無
- BANG-BIN CHEN 無
- 林明恩 無
- - - 無
- Chieh-Lung Cheng 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tsung-Jang Yeh 無
- Shih-Feng Cho 無
- 謝子禹 無
- Jeng-Shiun Du 無
- 王閔宏 無
- Yi-Chang Liu 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 王元欽 無
- Ming-Chung Kao 無
- 高小雯 無
- HSUAN JEN SHIH 無
- 陳寧君 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Ming-Yu Lien 無
- Ching-Chan Lin 無
- 陳珈妤 無
- Che-Hung Lin 無
- Tzu-Ting Chen 無
- Yu-Min Liao 無
- 王幸婷 無
- Chi-Ching Chen 無
- 鄭富銘 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
26 participants
-
Global
350 participants
